Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: An analysis of protein production and gene expression

American Journal of Otology

Volumn 17, Issue 2, 1996, Pages 203-206

  Bujia J ^a,d   Kim, C ^a   Holly, A ^a   Sudhoff, H ^b   Ostos, P ^c   Kastenbauer, E ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF CÓRDOBA   (Spain)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cholesteatoma; EGF R; ELISA; In situ hybridization

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CHOLESTEATOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MIDDLE EAR TUMOR; PRIORITY JOURNAL;

BINDING SITES; CHOLESTEATOMA; DNA PROBES; DNA, COMPLEMENTARY; EAR, MIDDLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; IN SITU HYBRIDIZATION; KERATINOCYTES; PROTEIN BIOSYNTHESIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0029998437     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Palva T. The pathogenesis and treatment of cholesteatoma. Acta Otolaryngol (Stockh) 1990;109:323-30.
2. Bujía J, Schililing V, Holly A, Stammberger M, Kastenbauer E. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 1993;113:364-8.
3. Stammberger M, Bujía J, Kasteubauer E. Alteration of epidermal differentiation in middle ear cholesteatoma. Am J Otol 1995;16:527-31.
4. Knopf B, Wollina U. Der Keratinozyt - eine biologisch aktive Zelle. Dermatol Monatsschr 1990;176:453-9.
5. Kupper TS. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 1990;94(suppl):146-50.
6. Hunter T. The epidermal growth factor gene and its product. Nature 1984;311:414-16.
7. Hunter T, Cooper JA. Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell 1981;24:741-52.
8. Bujía J, Holly A, Schilling V, Negri B, Pitzke P, Schulz P. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Larnygoscope 1993;103:326-9.
9. Firestein GS, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
10. Sittinger M, Bujia J, Burmester G. Inexpensive computer analysis of cell and tissue stainings. In Vitro Cell Dev Biol 1994;30A:559-61.
11. Schulz P, Bujía J, Holly A, Schilling V, Kastenbauer E. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha. Am J Otolaryngol 1993;14:82-7.
12. Sudhoff H, Fisseler-Eckhoff A, Bernal-Sprekelsen M, Müller KM, Hildmann H. Epidermal growth factor, transforming growth factor alpha and epidermal growth factor-receptor in cholesteatoma. Am J Otolaryngol (in press).
13. Yarden Y, Ullrich A. Molecular analysis of signal transduction by growth factors. Biochemistry 1988;27:3113-23.
14. Sudhoff H, Bujía J, Fisseler-Eckhoff A, et al. Expression of a cell-cycle-associated nuclear antigen (MIB-1) in cholesteatoma and auditory meatal skin. Laryngoscope 1995;105:1227-31.
15. Lim DJ. Epithelial invasion, contact guidance and contact inhibition. In: Sade J, ed. Cholesteatoma and mastoid surgery. Amsterdam: Kugler, 1982:175-80.
16. Sudhoff H, Bujía J, Fisseler-Eckhoff A, et al. Basement membrane in middle ear cholesteatoma. Immunohistochemical and ultrastructural observations. Ann Otol Rhinol Laryngol (in press).
17. Donaldson DJ, Mahan JT. Keratinocyte migration and extracellular matrix. J Invest Dermatol 1988;90:623-8.
18. Hay J, ed. Role of basement membranes in development and differentiation. In: Kefalides NA, ed. Biology and chemistry of basement membranes. New York: Academic Press, 1978:34-42.
19. Ahn JM, Huang CC, Abramson G. Interleukin-1 causing bone destruction in middle ear cholesteatoma. Otolaryngol Head Neck Surg 1990;103:527-36.
20. Schilling V, Bujía J, Negri B. Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol 1991;12:249-53.
21. Schilling V, Negri B, Bujía J, Schulz P, Kastenbauer E. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol 1992;13:350-5.
22. King LE, Gates RE, Christa M. Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. J Invest Dermatol 1990;95:10S-12S.
23. Nanney LB, Stoscheck CM, Kin LE, Underwood RA, Holbrook KA. Immunolocalization of epidermal growth factor receptor in normal and developing human skin. J Invest Dermatol 1990;94:742-8.
24. Bujía J, Wustrow TPU. Heterologous epidermal growth factor receptor (EGF-R) expression in larynx cancer cell lines: evidence for the existence of structurally modified receptors. Acta Otolaryngol (Stockh) 1993;113:789-92.
25. Neal DE, Marsh C, Bennett MK, Abel PD, Harris AL. Epidermal growth factor receptors in human bladder cancer: comparisons of invasive and superficial tumors. Lancet 1985;1:366-8.
26. Cowley G, Smith JA, Gusterson BA. Increased EGF receptors on human squamous carcinoma cell lines. Br J Cancer 1986;53:223-9.
27. Costa S, Stamm H, Almendral A. A predictive value of EGF receptor in breast cancer. Lancet 1988;1:1258.